eculizumab - CISMeF

Preferred Label : eculizumab;

UMLS semantic type : T116 - Amino Acid, Peptide, or Protein; T121 - Pharmacologic Substance; T129 - Immunologic Factor;

Is substance : O;

Details

Origin ID

M0461005;

UMLS CUI

C1541483;

Currated CISMeF NLP mapping
- Eculizumab [LOINC component]
- Eculizumab [SMS substance]
- Eculizumab [ICD-11 Extension code]
- Eculizumab [Anticorps monoclonal]
- Eculizumab [NCIt concept]
- Eculizumab (substance) [SNOMED CT concept]
- eculizumab [COVID-19 Thesaurus concept]
- eculizumab [International Nonproprietary Name]
MeSH narrower concept(s)
- 5G1.1 [MeSH concept]
- Alexion [MeSH concept]
- Elizaria [MeSH concept]
- soliris [MeSH concept]
Related record
- eculizumab [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Product containing eculizumab (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Eculizumab [LOINC component]
- Eculizumab [NCIt concept]
- Eculizumab (substance) [SNOMED CT concept]
- Product containing eculizumab (medicinal product) [SNOMED CT concept]
- eculizumab [ATC Code]
- eculizumab [International Nonproprietary Name]
Validated automatic mappings to BTNT
- eculizumab [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients